Didehydroretinoic acid: Retinoid receptor-mediated transcriptional activation and binding properties

Biochemical Pharmacology

Volumn 53, Issue 7, 1997, Pages 1049-1053

  Sani, Brahma P ^a   Venepally, Pratap R ^a   Levin, Arthur A ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

CRABPs; DDRA; IC50; RARs; RXRs; transcription

Indexed keywords

DIDEHYDRORETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CARCINOGENESIS; CELL DIFFERENTIATION; DRUG MECHANISM; PRIORITY JOURNAL; RECEPTOR BINDING; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; BINDING, COMPETITIVE; COS CELLS; HUMANS; MICE; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN; VITAMIN A;

EID: 0030984796     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00076-2     Document Type: Article

References (25)

1. Gudas LJ, Sporn MB and Roberts AB, Cellular biology and the biochemistry of retinoids. In: The Retinoids: Biology, Chemistry, and Medicine (Eds. Sporn MB, Roberts AB and Goodman DS), pp. 443-520. Raven Press, New York, 1994.
2. Leid M, Kastner P and Chambon P, Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem Sci 17: 427-433, 1992.
3. de Thé H, Chomienne C, Lanotte M, Degos L and Dejean A, The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347: 558-561, 1990.
4. Castleberry RP, Emanuel PD and Zuckerman KS, A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engi J Med 331: 501-518, 1994.
5. Mangelsdorf DJ, Umesono K and Evans RM, The retinoid receptors. In: The Retinoids: Biology, Chemistry, and Medicine (Eds. Sporn MB, Roberts AB and Goodman DS), pp. 319-349. Raven Press, New York, 1994.
6. Sani BP, Binding affinities of retinoids to their binding proteins/receptors and their biological activities. In Retinoids: Progress in Research and Clinical Applications (Eds. Livrea M and Packer L), pp. 247-257. Marcel Dekker, New York, 1993.
7. Ong DE, Newcomer ME and Chytil F, Cellular retinoid-binding proteins. In: The Retinoids: Biology, Chemistry, and Medicine (Eds. Sporn MB, Roberts AB and Goodman DS), pp. 283-317. Raven Press, New York, 1994.
8. Gudas LJ, Retinoids and vertebrate development. J Biol Chem 269: 15399-15402, 1994.
9. Buck J, Derguini F, Levi E, Nakanishi K and Hämmerling U, Intracellular signaling by 14-hydroxy-4,14-retro-retinol. Science 254: 1654-1656, 1991.
10. Vahlquist A, Vitamin A in human skin: I. Detection and identification of retinoids in normal epidermis. J Invest Dermatol 79: 89-93, 1982.
11. Thaller C and Eichele G, Isolation of 3,4-didehydroretinoic acid, a novel morphogenetic signal in the chick wing bud. Nature 345: 815-819, 1990.
12. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A and Grippo J, 9-cis-Retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355: 359-361, 1992.
13. Frolik CA, Roberts AB, Tavela TE, Roller PP, Newton DL and Sporn MB, Isolation and identification of 4-hydroxy- and 4-oxoretinoic acid. In vitro metabolites of all-trans-retinoic acid in hamster trachea and liver. Biochemistry 18: 2092-2097, 1979.
14. Pijnappel WWM, Hendriks HFJ, Folders GE, van den Brink CE, Dekker EJ, Edlenbosch C, van der Sang PT and Durston AJ, The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature 366: 340-344, 1993.
15. Kraft JC, Kimelman D and Juchau MR, Xenopus laevis: A model system for the study of embryonic retinoid metabolism. II. Embryonic metabolism of all-trans-3,4-didehydroretinol to didehydroretinoic acid. Drug Metab Dispos 23: 83-89, 1995.
16. Rollman O and Vahlquist A, Vitamin A in skin and serum-studies of acne vulgaris, atopic dermatitis, ichthyosis vulgaris and lichen planus. Br J Dermatol 113: 405-413, 1985.
17. Rollman O and Vahlquist A, Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol, and carotenoids in adult patients versus healthy controls. Arch Dermatol 278: 17-24, 1985.
18. Allenby G, Bocquell MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo J, Chambon P and Levin A, Retinoic acid receptors and retinoic acid X receptors: Interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90: 30-34, 1993.
19. Reynolds NJ, Fisher GJ, Griffiths CEM, Tavakkol A, Talwar HS, Rowse PE, Hamilton TA and Voorhees JJ, Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells, and hairless mouse skin in vivo. J Pharmacol Exp Ther 266: 1636-1642, 1993.
20. Torma H, Asselineau D, Andersson E, Martin B, Reiniche P, Chambon P, Shroot B, Darmon M and Vahlquist A, Biologic activities of retinoic acid and 3,4-didehydroretinoic acid in human keratinocytes are similar and correlate with receptor affinities and transactivation properties. J Invest Dermatol 102: 49-54, 1994.
21. Sani BP, Venepally P, Zhang X-k, Hill DL and Shealy YF, Biochemical characteristics and differentiating activity of 4-oxo analogs of retinoic acid. Anticancer Res 16: 1177-1182, 1996.
22. Venepally PR and Sani BP, Analysis of the effects of CRABP I expression on the transcription mediated by retinoid receptors. Biochemistry 35: 9974-9982, 1996.
23. Alam M, Zhestkov V, Sani BP, Venepally P, Levin AA, Kazmer S, Li E, Norris AW, Zhang X-k, Lee M-O, Hill DL, Lin T-H, Brouillette WJ and Muccio DD, Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity. J Med Chem 38: 2302-2310, 1995.
24. Fiorella PD, Giguère V and Napoli NL, Expression of cellular retinoic acid-binding protein (type II) in Escherichia coli. Characterization and comparison to cellular retinoic acid-binding protein (type I). J Biol Chem 268: 21545-21552, 1993.
25. Sani BP, Grippo JF and Levin AA, 9-cis-Retinoic acid binds cellular retinoic acid-binding protein with low affinity. Oncol (Life Sea Adv) 13: 21-27, 1994.